2015 annual financial data
Summit Therapeutics 2015 Net margin
Direct answer
Net margin was -1,571.98%.
Operating income was -20,346,000 GBP and net income was -20,137,000 GBP.
Operating cash flow was -24,470,554 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,281,000 GBP
- Operating income
- -20,346,000 GBP
- Net income
- -20,137,000 GBP
- Operating cash flow
- -24,470,554 GBP